First case report of an adrenocortical carcinoma caused by a BRCA2 mutation

Medicine (Baltimore). 2016 Sep;95(36):e4756. doi: 10.1097/MD.0000000000004756.

Abstract

Background: Adrenocortical carcinoma (ACC) may rarely be a component of inherited cancer syndromes such as Li-Fraumeni syndrome and Beckwith-Wiedemann syndrome. ACC caused by a BRCA2 mutation has never been reported.

Methods: Nucleotide sequencing of BRCA2 in lymphocyte and tumoral DNA of a 50-year-old male who presented with an androgen-secreting ACC and a strong family history of breast, ovarian, and pancreatic cancers.

Results: A germline BRCA2 2 bp heterozygous deletion at nucleotide 8765 (8765delAG) leading to a frameshift mutation (p.Glu2846GlyfsX23) was detected. Only the BRCA2 deleted allele was retained in the ACC tumoral DNA compared with the control DNA supporting a loss of heterozygosity in the tumor.

Conclusion: This is the first reported case of a patient with ACC associated with a BRCA2 germline mutation. Loss of heterozygosity in ACC DNA suggests a causal link with the BRCA2 8765delAG mutation.

Publication types

  • Case Reports

MeSH terms

  • Adrenal Cortex Neoplasms / genetics*
  • Adrenocortical Carcinoma / genetics*
  • Adult
  • Breast Neoplasms / genetics*
  • Female
  • Genes, BRCA2*
  • Germ-Line Mutation
  • Heterozygote
  • Humans
  • Male
  • Middle Aged
  • Pedigree